In this study, we investigate the anti-cancer effects of luteolin on EJ138 BC malignant cells by examining its impact on autophagic, apoptotic, and metastatic gene modulation, specifically targeting ATG12, ULK1, P53, BCL2, MMP2, and MMP9. This evidence concerns the gene BCL2 and breast cancer.